Category: Thomson ReutersSyndicate content

VCs put more into medtech last year | Medtech funding for the week of January 19, 2015

January 23, 2015 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: VCs put more into fewer medtech deals last year; Samsung leads $20m round for EarlySense; K2M registers for $40m follow-on

Report: VCs put more into fewer medtech deals last year

January 20, 2015 by Brad Perriello

Report: VCs put more into fewer medtech deals last year

January 20, 2015 by Brad Perriello

The collective value of venture capital investments in medical device companies surged last year even as deal volumes were flat, according to the MoneyTree report.

Report: VCs put more into fewer medtech deals last year

Venture capitalists put more cash into fewer deals backing medical device companies last year, according to the MoneyTree report, meaning that the average deal value rose nearly 28% in 2014.

Shares soar for InVivo after spinal cord study update | Medtech Wall Street news for the week of November 17, 2014

November 20, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: InVivo shares soar on spinal cord study update; Actavis trumps Valeant with $66B offer for Allergan; Medtronic's Q2 results meet The Street; Venture capital investment in medtech grows in Q3

InVivo shares soar on spinal cord study update

November 13, 2014 by Val Kennedy

Venture capital investment in medtech grows in Q3

November 18, 2014 by Brad Perriello

Venture capital investment in medical device companies rose in terms of both value and volume during the 3rd quarter, compared with the same period last year, according to PricewaterhouseCoopers.

Venture capital investment in medtech grows in Q3

Venture capitalists put more cash into more deals for medical device companies during the 3rd quarter, according to a report from PricewaterhouseCoopers.

Medical device companies pulled down $586 million in 78 deals during the 3rd quarter, up 13% in dollars and 18% in deal volume compared with Q3 2013.

Five major factors will determine the future of the medical device industry | Medtech Wall Street news for the week of October 20, 2014

October 23, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: 5 factors affecting the future of medtech; Medtech VC deals post double-digit increases in Q3; Breast implant maker Sientra sets IPO range; GE CEO Immelt: Global experience got Flannery the top spot at GE Healthcare; GI Dynamics proposes 1-for-10 reverse stock split

5 factors affecting the future of medtech

October 20, 2014 by Brad Perriello

5 factors affecting the future of medtech

Medtech VC deals post double-digit increases in Q3

October 17, 2014 by Brad Perriello

Venture capital investment in medical device companies rose both in terms of value and volume during the 3rd quarter, according to the MoneyTree report from PricewaterhouseCoopers and the National Venture Capital Assn., based on Thomson Reuters data.

YYmeta

Venture capital shops got behind medtech during the 3rd quarter, increasing their spend and the number of deals compared with the same period last year, according to the MoneyTree report from PricewaterhouseCoopers and the National Venture Capital Assn., based on Thomson Reuters data.